|
1
|
Ivanova A, Liao SY, Lerman MI, Ivanov S
and Stanbridge EJ: STRA13 expression and subcellular localisation
in normal and tumour tissues: implications for use as a diagnostic
and differentiation marker. J Med Genet. 42:565–576. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shen M, Kawamoto T, Yan W, et al:
Molecular characterization of the novel basic helix-loop-helix
protein DEC1 expressed in differentiated human embryo chondrocytes.
Biochem Biophys Res Commun. 236:294–298. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakashima A, Kawamoto T, Honda KK, et al:
DEC1 modulates the circadian phase of clock gene expression. Mol
Cell Biol. 28:4080–4092. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sato F, Bhawal UK, Kawamoto T, et al:
Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively
regulates vascular endothelial growth factor expression. Genes
Cells. 13:131–144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Sato F, Kawamoto T, et al:
Anti-apoptotic effect of the basic helix-loop-helix (bHLH)
transcription factor DEC2 in human breast cancer cells. Genes
Cells. 15:315–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhawal UK, Sato F, Arakawa Y, et al: Basic
helix-loop-helix transcription factor DEC1 negatively regulates
cyclin D1. J Pathol. 224:420–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Zhang H, Xie M, et al: Abundant
expression of Dec1/stra13/sharp2 in colon carcinoma: its
antagonizing role in serum deprivation-induced apoptosis and
selective inhibition of procaspase activation. Biochem J.
367:413–422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boudjelal M, Taneja R, Matsubara S,
Bouillet P, Dolle P and Chambon P: Overexpression of Stra13, a
novel retinoic acid-inducible gene of the basic helix-loop-helix
family, inhibits mesodermal and promotes neuronal differentiation
of P19 cells. Genes Dev. 11:2052–2065. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Turley H, Wykoff CC, Troup S, Watson PH,
Gatter KC and Harris AL: The hypoxia-regulated transcription factor
DEC1 (Stra13, SHARP-2) and its expression in human tissues and
tumours. J Pathol. 203:808–813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi XH, Zheng Y, Sun Q, et al: DEC1
nuclear expression: a marker of differentiation grade in
hepatocellular carcinoma. World J Gastroenterol. 17:2037–2043.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Q, Ma P, Hu C, et al: Overexpression of
the DEC1 protein induces senescence in vitro and is related to
better survival in esophageal squamous cell carcinoma. PLoS One.
7:e418622012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chakrabarti J, Turley H, Campo L, et al:
The transcription factor DEC1 (stra13, SHARP2) is associated with
the hypoxic response and high tumour grade in human breast cancers.
Br J Cancer. 91:954–958. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tokés AM, Kulka J, Paku S, et al:
Claudin-1, -3 and -4 proteins and mRNA expression in benign and
malignant breast lesions: a research study. Breast Cancer Res.
7:R296–R305. 2005.PubMed/NCBI
|
|
14
|
Swisshelm K, Macek R and Kubbies M: Role
of claudins in tumorigenesis. Adv Drug Deliv Rev. 57:919–928. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheehan GM, Kallakury BV, Sheehan CE,
Fisher HA, Kaufman RP Jr and Ross JS: Loss of claudins-1 and -7 and
expression of claudins-3 and -4 correlate with prognostic variables
in prostatic adenocarcinomas. Hum Pathol. 38:564–569. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cohn ML, Goncharuk VN, Diwan AH, Zhang PS,
Shen SS and Prieto VG: Loss of claudin-1 expression in
tumor-associated vessels correlates with acquisition of metastatic
phenotype in melanocytic neoplasms. J Cutan Pathol. 32:533–536.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chao YC, Pan SH, Yang SC, et al: Claudin-1
is a metastasis suppressor and correlates with clinical outcome in
lung adenocarcinoma. Am J Respir Crit Care Med. 179:123–133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Myal Y, Leygue E and Blanchard AA: Claudin
1 in breast tumorigenesis: revelation of a possible novel ‘claudin
high’ subset of breast cancers. J Biomed Biotechnol.
2010:9568972010.PubMed/NCBI
|
|
19
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, et al: DEC1 (STRA13) protein expression relates to
hypoxia-inducible factor 1-alpha and carbonic anhydrase-9
overexpression in non-small cell lung cancer. J Pathol.
200:222–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morohashi S, Kusumi T, Sato F, et al:
Decreased expression of claudin-1 correlates with recurrence status
in breast cancer. Int J Mol Med. 20:139–143. 2007.PubMed/NCBI
|
|
21
|
Ivanova AV, Ivanov SV,
Danilkovitch-Miagkova A and Lerman MI: Regulation of STRA13 by the
von Hippel-Lindau tumor suppressor protein, hypoxia, and the
UBC9/ubiquitin proteasome degradation pathway. J Biol Chem.
276:15306–15315. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Xie M, Yang D, et al: The expression
of antiapoptotic protein survivin is transcriptionally upregulated
by DEC1 primarily through multiple sp1 binding sites in the
proximal promoter. Oncogene. 25:3296–3306. 2006. View Article : Google Scholar
|
|
23
|
Anderson JM and Van Itallie CM: Physiology
and function of the tight junction. Cold Spring Harb Perspect Biol.
1:a0025842009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Diamond JM: Twenty-first Bowditch lecture.
The epithelial junction: bridge, gate, and fence. Physiologist.
20:10–18. 1977.PubMed/NCBI
|
|
25
|
Tobioka H, Isomura H, Kokai Y, Tokunaga Y,
Yamaguchi J and Sawada N: Occludin expression decreases with the
progression of human endometrial carcinoma. Hum Pathol. 35:159–164.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blanchard AA, Watson PH, Shiu RP, et al:
Differential expression of claudin 1, 3, and 4 during normal
mammary gland development in the mouse. DNA Cell Biol. 25:79–86.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Xie M, Song X, et al: DEC1
negatively regulates the expression of DEC2 through binding to the
E-box in the proximal promoter. J Biol Chem. 278:16899–16907. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
St-Pierre B, Flock G, Zacksenhaus E and
Egan SE: Stra13 homodimers repress transcription through class B
E-box elements. J Biol Chem. 277:46544–46551. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martinez-Estrada OM, Cullerés A, Soriano
FX, et al: The transcription factors Slug and Snail act as
repressors of Claudin-1 expression in epithelial cells. Biochem J.
394:449–457. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kon N, Hirota T, Kawamoto T, Kato Y,
Tsubota T and Fukada Y: Activation of TGF-beta/activin signalling
resets the circadian clock through rapid induction of Dec1
transcripts. Nat Cell Biol. 10:1463–1469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Y, Wang L, Lin XY, et al:
Anti-apoptotic effect of claudin-1 on TNF-α-induced apoptosis in
human breast cancer MCF-7 cells. Tumour Biol. 33:2307–2315.
2012.PubMed/NCBI
|
|
33
|
Wu Y, Sato F, Yamada T, et al: The BHLH
transcription factor DEC1 plays an important role in the
epithelial-mesenchymal transition of pancreatic cancer. Int J
Oncol. 41:1337–1346. 2012.PubMed/NCBI
|
|
34
|
Kondo J, Sato F, Kusumi T, et al:
Claudin-1 expression is induced by tumor necrosis factor-α in human
pancreatic cancer cells. Int J Mol Med. 22:645–649. 2008.
|
|
35
|
Bruna A, Greenwood W, Le Quesne J, et al:
TGFβ induces the formation of tumour-initiating cells in
claudinlow breast cancer. Nat Commun. 3:10552012.
|
